Brian A. Moser

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 273 citations

Medicine, Pharmacology, Pharmacotherapy +17

Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans

Michael Man, Mark W. Farmen, Carmen M. Dumaual et al. · The Journal of Clinical Pharmacology · 2010 · 216 citations

Veterinary Medicine, Genetics, Pharmacology +17

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Dominick J. Angiolillo, Joseph A. Jakubowski, José Luis Ferreiro et al. · Journal of the American College of Cardiology · 2014 · 180 citations

Medicine, Cardiology, Pharmacology +17

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

David Erlinge, Paul A. Gurbel, Stefan James et al. · Journal of the American College of Cardiology · 2013 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +16

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

David Erlinge, Jurriën M. ten Berg, David P. Foley et al. · Journal of the American College of Cardiology · 2012 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +17